World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
46634
World Ranking
6712
National Ranking
3543

James A. Fagin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James A. Fagin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 320 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James A. Fagin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James A. Fagin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

James A. Fagin is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research contributions span multiple fields including Medicine, Biochemistry, Genetics and Molecular Biology, with a strong focus on the subfields of Endocrinology, Diabetes and Metabolism, Molecular Biology, Oncology, Genetics, and Radiology, Nuclear Medicine and Imaging.

The scientist's work concentrates mainly on the diagnosis and treatment of thyroid cancer, a topic prominently reflected across many of their publications. Other significant research topics include cancer-related molecular pathways, BRCA gene mutations in cancer, ferroptosis and cancer prognosis, cancer genomics and diagnostics, genetic factors in colorectal cancer, and radiopharmaceutical chemistry and applications.

Recent key publications by James A. Fagin include:

  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis (2020), Nature Genetics
  • Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases (2020), Thyroid
  • SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies (2020), Cancer Discovery
  • The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers (2022), Nature Communications
  • American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment (2022), Head & Neck

James A. Fagin has published extensively in several academic journals. The venues with the highest frequency of their publications include:

  • Thyroid
  • Journal of Clinical Oncology
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Discovery

The scientist has collaborated frequently with a core group of co-authors, including:

  • Ronald Ghossein
  • Eric J. Sherman
  • Alan L. Ho
  • Gnana P. Krishnamoorthy
  • Jeffrey A. Knauf

Among their recognitions, James A. Fagin is a member of the Association of American Physicians. Their scholarly output and collaborative efforts contribute to multiple aspects of cancer biology, with a clear emphasis on molecular and clinical aspects of thyroid cancer and related malignancies.

Best Publications

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.

    Edna T. Kimura;Marina N. Nikiforova;Zhaowen Zhu;Jeffrey A. Knauf

  • Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

    Samuel A. Wells;Bruce G. Robinson;Robert F. Gagel;Henning Dralle

  • BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

    Marina N. Nikiforova;Edna Teruko Kimura;Manoj Gandhi;Paul W. Biddinger

  • Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

    Iñigo Landa;Tihana Ibrahimpasic;Laura Boucai;Rileen Sinha

  • Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

    Michael Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;David Viola

  • Biologic and Clinical Perspectives on Thyroid Cancer

    James A. Fagin;Samuel A. Wells

  • Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    Alan L. Ho;Ravinder K. Grewal;Rebecca Leboeuf;Eric J. Sherman

  • Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules

    Yuri E. Nikiforov;David L. Steward;Toni M. Robinson-Smith;Bryan R. Haugen

  • High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.

    J. A. Fagin;K. Matsuo;A. Karmakar;Dan Lin Chen

  • Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

    Yuri E. Nikiforov;Jon M. Rowland;Kevin E. Bove;Hector Monforte-Munoz

  • A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.

    James S. Forrester;Michael Fishbein;Richard Helfant;James Fagin

  • Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

    R. Michael Tuttle;Hernan Tala;Jatin Shah;Rebecca Leboeuf

  • Clonal Origin of Pituitary Adenomas

    Vivien Herman;James Fagin;Rivkah Gonsky;Kalman Kovacs

  • Mutational Profile Of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA and AKT1

    Julio C. Ricarte-Filho;Mabel Ryder;Dhananjay A. Chitale;Michael Rivera

  • Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

    Rebecca E. Schweppe;Joshua P. Klopper;Christopher Korch;Umarani Pugazhenthi

  • Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas

    Piro Lito;Christine A. Pratilas;Eric W. Joseph;Madhavi Tadi

  • Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

    Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;Young Kee Shong

  • Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.

    Raffaele Ciampi;Jeffrey A. Knauf;Roswitha Kerler;Manoj Gandhi

  • AssociationBetween BRAFV600EMutationand MortalityinPatientsWithPapillaryThyroidCancer

    Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;David Viola

Frequent Co-Authors

Ronald Ghossein
Ronald Ghossein Memorial Sloan Kettering Cancer Center
Yuri E. Nikiforov
Yuri E. Nikiforov University of Pittsburgh
R. Michael Tuttle
R. Michael Tuttle Memorial Sloan Kettering Cancer Center
Shlomo Melmed
Shlomo Melmed Cedars-Sinai Medical Center
Ian Ganly
Ian Ganly Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
David G. Pfister
David G. Pfister Memorial Sloan Kettering Cancer Center
Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
Ashok R. Shaha
Ashok R. Shaha Memorial Sloan Kettering Cancer Center
Thomas L. Clemens
Thomas L. Clemens United States Department of Veterans Affairs

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t only mean traditional MD and DO programs. For those interested in nursing and allied health tracks, a variety of flexible online degrees are making advanced qualifications more accessible than ever.

If you already hold a BSN, you might consider accelerated dnp programs to fast-track your rise to a leadership or advanced practice role. Cost is a major concern for many students, so looking at options like cheapest online dnp programs can help manage tuition expenses without compromising on program quality.

Those seeking a quick pathway into nursing can investigate 9 month lpn program options, offering a practical entry to health care and paving the way for further study. Meanwhile, registered nurses eager to specialize may explore flexible bsn to np programs online, especially for high-demand fields like psychiatric mental health.

Online programs open new and efficient routes into medical and nursing careers, helping you tailor your educational journey to your schedule and goals.

Best Scientists Citing James A. Fagin

Trending Scientists

Recently Published Articles